Bio-Techne Collaborates with Wyss Center to Enhance Multiomic Analysis in 3D Tissue Specimens

Bio-Techne Partners with Wyss Center to Advance Multiomic Analysis in 3D Tissue Specimens

Bio-Techne Corporation has forged a strategic alliance with the Wyss Center for Bio and Neuroengineering in Geneva, focusing on the development of an automated workflow for simultaneous RNA and protein detection in three-dimensional tissue specimens. This collaboration signifies a crucial advancement in the realm of multiomic analysis, which intertwines genomic, transcriptomic, and proteomic data to provide comprehensive insights into biological systems. Through this partnership, Bio-Techne aims to enhance researchers' ability to decipher complex tissue structures and cellular interactions, moving beyond the limitations imposed by traditional methods of analysis.

The new automated detection process is designed to streamline the workflow associated with multiomic studies, which have historically been labor-intensive and fraught with technical challenges. By minimizing manual intervention and increasing efficiency, Bio-Techne and Wyss Geneva hope to make these advanced techniques more accessible to researchers across various fields. This collaboration aligns with the growing momentum towards New Approach Methodologies (NAMs) in life sciences, including the use of organoids and AI-driven predictive modeling, which promise to reduce the reliance on animal testing while fostering more ethical research practices.

According to Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, this collaboration opens new avenues for preclinical modeling, crucial for enhancing drug discovery and diagnostic development. Dr. Stéphane Pages, Director of Neuroimaging at Wyss Geneva, emphasizes that unlocking the potential of three-dimensional multiomics is vital for revolutionizing biological understanding. The shared goal of making these innovative technologies widely accessible reflects a commitment to accelerating scientific progress while addressing the ethical implications of research in the life sciences sector.

In addition to this partnership, Bio-Techne is actively expanding its spatial biology capabilities, which are essential for navigating the complexities of biological systems. The company’s focus on high-resolution insights not only drives innovation in the field but also plays a significant role in shaping future biomedical studies.

By prioritizing the integration of advanced technologies and addressing existing technical barriers, Bio-Techne is poised to lead a transformative shift in how researchers engage with spatial biology, ultimately enhancing the impact of their findings in the life sciences.